Primary biliary cholangitis: personalized medicine for optimal therapeutic opportunities

Affiliations

¹ National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Military Medical University, Xi'an 710032, China.
² Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis 95616, USA.
³ Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis 95616, USA. Electronic address: megershwin@ucdavis.edu.
⁴ National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Military Medical University, Xi'an 710032, China. Electronic address: hanying@fmmu.edu.cn.

Yulong Shang et al. Sci Bull (Beijing). 2022.

. 2022 Dec 31;67(24):2498-2501.

doi: 10.1016/j.scib.2022.11.029. Epub 2022 Dec 1.

¹ National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Military Medical University, Xi'an 710032, China.
² Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis 95616, USA.
³ Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis 95616, USA. Electronic address: megershwin@ucdavis.edu.
⁴ National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Military Medical University, Xi'an 710032, China. Electronic address: hanying@fmmu.edu.cn.

No abstract available

Conflict of interest statement

Conflict of interest The authors declare that they have no conflict of interest.